Effects of a Mindfulness-Based Intervention on Event-Related Potentials (P3) and Depressive Symptoms in Oncological Patients.
Theresa Schweig, Madeleine Fink, Kira Schmidt, Marvin Krawutschke, Saskia Pasche, Eva-Maria Skoda, Martin Teufel, Bernhard W Müller
Integrative cancer therapies January 1, 2024 DOI: 10.1177/15347354241294057 via PubMed
Summary
AI-generated from the abstractIn a small clinical trial, 17 cancer patients (average age 51, 11 women) completed a 5-week mindfulness-based intervention (two group sessions per week) while their brain responses to emotional images were measured via event-related potentials. Changes in the P3 brainwave component depended on both the emotional valence (positive vs. negative) and arousal level of the images. After the intervention, P3 amplitudes at the frontal electrode site Fz decreased significantly compared to before treatment, suggesting reduced neural reactivity to emotional stimuli. Depressive symptoms also showed a trend toward improvement. The findings indicate that mindfulness training may alter how the brain processes emotional information in cancer patients, with the strongest effects at frontal brain regions.
Study at a glance
| Characteristics | Waitlist-controlled clinical trial Peer reviewed |
|---|---|
| Sample size | 17 |
| Population | Oncological patients |
| Intervention | Mindfulness-based intervention |
| Duration | 5-week intervention |
| Topics | Depression Meditation |
| Keywords | P3 Cancer Event-related potentials erps |
| Key finding | P3 amplitudes at the frontal electrode Fz decreased significantly after a mindfulness-based intervention in cancer patients, and depressive symptoms showed a trend toward reduction. |
Abstract
Objective: The aim of this study was to investigate changes in P3 amplitude and latency to emotional stimuli with different arousal and valence levels after a mindfulness-based intervention in oncological patients. Methods: P3 amplitude and latency at Fz, Cz, and Pz to emotional salient stimuli differing in valence (positive vs. negative) and arousal (low vs. high) levels were measured in 17 oncological patients (Mage = 51 years, SD = 9.17, females = 11) before and after a mindfulness-based intervention in a waitlist-controlled clinical trial. Group sessions were held 2x/week over a period of 5 weeks. Results: Arousal and valence levels of emotional salient stimuli were significant modulators of P3 amplitudes (P = .050; P = .006, respectively). P3 amplitudes at Fz decreased significantly from pre-waitlist to post-intervention (P = .002). P3 latency for negatively valenced stimuli decreased from pre- to post-intervention with trending significance (P = .080). P3 latency at Pz showed a trend of being shorter than P3 latency at Cz (P = .066). Depressive symptoms showed a decreasing trend from pre- to post-treatment (P = .075). Conclusions: We could show that arousal and valence levels of emotional salient stimuli are important modulators of P3 amplitudes and latencies in oncological patients. P3 amplitudes at Fz decreased significantly from pre-waitlist until after mindfulness-based intervention, decreases from pre-to post-intervention were linear, but not significant. In oncological patients the mindfulness-based intervention seems to have its strongest effect on the frontal electrode Fz, not the electrode Pz where its amplitude was largest. Depressive symptoms could be reduced.